SIBN_logo.jpg
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2022 and Updates Guidance
November 07, 2022 16:09 ET | SI-BONE, Inc.
SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported...
SIBN_logo.jpg
SI-BONE To Report Third Quarter 2022 Financial Results on November 7, 2022
October 17, 2022 16:04 ET | SI-BONE, Inc.
SANTA CLARA, Calif., Oct. 17, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE_logo.png
SI-BONE To Present at The Morgan Stanley 20th Annual Global Healthcare Conference
August 23, 2022 08:02 ET | SI-BONE, Inc.
SANTA CLARA, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE_logo.png
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2022
August 08, 2022 16:02 ET | SI-BONE, Inc.
SANTA CLARA, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported...
SI-BONE_logo.png
SI-BONE To Present at The Canaccord Genuity 42nd Annual Growth Conference 2022
July 18, 2022 08:00 ET | SI-BONE, Inc.
SANTA CLARA, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE_logo.png
SI-BONE To Report Second Quarter 2022 Financial Results on August 8, 2022
July 18, 2022 08:00 ET | SI-BONE, Inc.
SANTA CLARA, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE, Inc. Announces FDA Clearance for Expanded Indication of the iFuse-TORQ® Implant System
June 13, 2022 08:00 ET | SI-BONE, Inc.
SANTA CLARA, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (SIBN), (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the...
SI-BONE, Inc. Receives FDA 510(k) Clearance for iFuse Bedrock Granite, a Breakthrough Pelvic Fixation and Fusion Technology
May 31, 2022 08:00 ET | SI-BONE, Inc.
SANTA CLARA, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic...
SI-BONE_logo.png
SI-BONE, Inc. Reports First Quarter 2022 Financial Results
May 09, 2022 16:02 ET | SI-BONE, Inc.
SANTA CLARA, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported...
SI-BONE_logo.png
SI-BONE, Inc. Announces New Technology Add-On Payment for Breakthrough Adult Spinal Deformity Treatment
April 19, 2022 08:00 ET | SI-BONE, Inc.
SANTA CLARA, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic...